The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1486
ISSUE1486
January 18, 2016
Fluad - An Adjuvanted Seasonal Influenza Vaccine for Older Adults
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Fluad - An Adjuvanted Seasonal Influenza Vaccine for Older Adults
January 18, 2016 (Issue: 1486)
The FDA has approved Fluad (Seqirus), an adjuvanted
trivalent seasonal influenza vaccine, for immunization
of adults ≥65 years old. It will become available later
this year for use during the 2016-2017 influenza
season. Fluad is the second...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.